NCT00852449

Brief Summary

Postoperative organ dysfunction severely affects the prognosis of surgical patients. Despite several trials evaluating restrictive or liberal fluid strategies, the ideal fluid replacement strategy remains controversial. Owing to the risk of altered tissue perfusion, a key trigger of organ dysfunction, the purpose of this study was to compare the influence of restrictive and liberal fluid regimens, using a goal-directed approach, on hypovolemia and postoperative organ dysfunction.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2008

Shorter than P25 for phase_4

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 27, 2009

Completed
Last Updated

October 5, 2012

Status Verified

October 1, 2012

Enrollment Period

8 months

First QC Date

February 26, 2009

Last Update Submit

October 4, 2012

Conditions

Keywords

Intraoperative fluidMonitoringOesophageal DopplerAbdominal surgerymajor abdominal surgery

Outcome Measures

Primary Outcomes (1)

  • incidence of intraoperative hypovolemia

    intraoperative

Secondary Outcomes (1)

  • postoperative organ failure postoperative complications (included anastomotic leak, perianastomotic abscess)

    postoperative

Study Arms (2)

restrictive fluid

EXPERIMENTAL

Restrictive fluid administration: 6 ml kg-1 h-1 of crystalloids (lactated Ringer's solution)

Other: restrictive and liberal fluid therapy

liberal fluid

EXPERIMENTAL

Liberal fluid administration: 12 ml kg-1 h-1 of crystalloids (lactated Ringer's solution)

Other: restrictive and liberal fluid therapy

Interventions

In both group, when hypovolemia is suspected (peak aortic velocity variation \> 13%): fluid bolus (hydroxyethyl starch 130/0.4/6%) according to a predefined algorithm designed to maintain peak aortic velocity \< 13% and no further increases in SV

liberal fluidrestrictive fluid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Major intraabdominal surgery

You may not qualify if:

  • Age \< 18 years
  • Pregnancy
  • Body mass index \> 35 kg/m2
  • Emergency surgery
  • Coagulopathy
  • Sepsis or Systemic inflammatory response syndrome (SIRS)
  • Hepatic failure (prothrombin ratio \< 50%, factor V \< 50%)
  • Contraindication for epidural analgesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Futier E, Constantin JM, Petit A, Chanques G, Kwiatkowski F, Flamein R, Slim K, Sapin V, Jaber S, Bazin JE. Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: A prospective randomized trial. Arch Surg. 2010 Dec;145(12):1193-200. doi: 10.1001/archsurg.2010.275.

  • Futier E, Robin E, Jabaudon M, Guerin R, Petit A, Bazin JE, Constantin JM, Vallet B. Central venous O(2) saturation and venous-to-arterial CO(2) difference as complementary tools for goal-directed therapy during high-risk surgery. Crit Care. 2010;14(5):R193. doi: 10.1186/cc9310. Epub 2010 Oct 29.

MeSH Terms

Conditions

Hypovolemia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Emmanuel Futier

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2009

First Posted

February 27, 2009

Study Start

May 1, 2008

Primary Completion

January 1, 2009

Study Completion

January 1, 2009

Last Updated

October 5, 2012

Record last verified: 2012-10